PCM
MD icon

Peregrine Capital Management’s Pediatrix Medical MD Stock Holding History

Peregrine Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-208,214
Closed -$11.1M – 258
2017
Q4 		$11.1M Buy
208,214
+15,384
+8% +$726K 0.26% 150
2017
Q3 		$8.31M Buy
+192,830
New +$9.16M 0.2% 209

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Peregrine Capital Management's MD Position: Q1 2018 in Review

Peregrine Capital Management sold out of Pediatrix Medical (MD) in Q1 2018, closing a stake of 208,214 shares — an estimated $11.1M sold.

Peregrine Capital Management first reported a position in MD in Q3 2017 and held it in 2 quarters. The position peaked at $11.1M in Q4 2017. 342 funds tracked by Wall St. Rank hold MD as of Q1 2018.

  • Peregrine Capital Management reported no remaining Pediatrix Medical position as of Q1 2018 after selling out during the quarter.
  • Peregrine Capital Management sold 208,214 Pediatrix Medical shares in Q1 2018, an estimated $11.1M.
  • Peregrine Capital Management first reported a position in Pediatrix Medical in Q3 2017 and held it in 2 quarters.
  • Peregrine Capital Management's Pediatrix Medical position peaked at $11.1M in Q4 2017.
  • 342 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2018.

Based on Peregrine Capital Management's 13F filing for Q1 2018, filed 16 Apr 2018.